Navigation Links
HybridSPE(TM)-Precipitation Technology Wins SelectScience.net 2009 Scientists' Choice Award for Best New Separations Product in 2008
Date:4/8/2009

HybridSPE-Precipitation (HybridSPE-PPT) technology combines the simplicity of protein precipitation with the selectivity of SPE for the targeted removal of phospholipids and proteins from biological samples prior to LC-MS/MS analysis

ST. LOUIS, April 8 /PRNewswire-FirstCall/ -- Supelco, a division of Sigma-Aldrich (Nasdaq: SIAL), and a leading supplier of chromatography products for analysis and purification, announces that its HybridSPE-Precipitation technology (http://www.sigma-aldrich.com/hybridspe-ppt) has won the SelectScience.net 2009 Scientists' Choice Award for Best New Separations Product in 2008. SelectScience.net is one of the leading online resources for applied chemists, clinical chemists and life scientists. The Scientists' Choice Award was based on an independent poll of over 25,000 scientists within the SelectScience.net community. The award was announced at Pittconn(R) 2009 held recently in Chicago, IL.

"The advent of LC-MS technology has resulted in a wealth of benefits in terms of analysis speed and sensitivity, but sample prep still was a bottleneck within the overall bioanalytical process," said An Trinh, Product Manager of Sample Prep at Supelco. "Our goal was to deliver a new and innovative sample prep platform that would be simple enough in use to employ in a high throughput setting while simultaneously improving the overall quality of the researchers' data. We are very happy to learn that our efforts have been recognized by the scientific community."

HybridSPE-Precipitation (HybridSPE-PPT) technology is a simple and generic sample preparation platform designed for the gross level removal of endogenous protein and phospholipid interferences from
'/>"/>

SOURCE Sigma-Aldrich
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
2. Novel Technology Breaks Through Cancer Pain
3. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
4. Advanced Cell Technology Announces Proposed Financing
5. Advanced Cell Technologys Dr. Robert Lanza Makes List of 100 Most Inspiring People in the Life-Sciences Industry
6. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
7. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
8. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
9. MedImmune Licenses Reverse Genetics Technology to Novartis for Use in Influenza Vaccine Development and Production
10. China Technology Announces New Chief Financial Officer
11. Medinet Licenses MaxCyte Cell Loading Technology for Cancer Immunotherapy in Japan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... 2014 Nuvilex, Inc. (OTCQB: NVLX) – According ... worldwide are living with diabetes, with  that number expected ... global market for diabetes treatments is approximately $500 billion.  ... died from pancreatic cancer.  Pancreatic cancer is the fourth ... the United States , and according ...
(Date:10/22/2014)... HONG KONG , Oct. 22, 2014 /PRNewswire/ ... announced today that rare disease expert John C. ... research. Dr. McKew brings more than two decades of ... the National Institutes of Health, Wyeth Research and Genetics ... will lead aTyr,s efforts to expand and translate its ...
(Date:10/20/2014)... YORK , Oct. 20, 2014 ... their experimental ZMapp™ antibody therapeutic to fight the ... how difficult and time-consuming the production of pharmaceuticals ... market research publisher said that while some may ... of this compound, those with industry knowledge are ...
(Date:10/20/2014)... 20, 2014 Asterias Biotherapeutics, Inc. (NYSE ... signed a Notice of Grant Award (NGA) with ... October 1, 2014.  The NGA provides for the ... release of additional grant funds pursuant to the ... clinical development of Asterias, product, AST-OPC1. The grant ...
Breaking Biology Technology:Nuvilex Brief Analyst Report: Thinking Outside the Box by BrokerBank Securities, Inc. 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 2Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4
... XIFIN Inc., the leading provider of revenue ... that XIFIN,s CEO and Executive Chairman, Lale ... College Conference in New Orleans on April ... executives, laboratory administrators and pathologists from many ...
... friendlyHOUSTON, April 14 US Oncology, Inc., supporting the nation,s ... Web site, usoncology.com . In order to ... usoncology.com is part of a new branding effort ... aspect of cancer care. , , For the ...
... field of medical microbiology, biodefense and pathogens to febit, ... and HEIDELBERG, Germany, April 14 febit ... Ph.D., for its Scientific Advisory Board. Dr. Keim ... Division at TGen (The Translational ...
Cached Biology Technology:XIFIN Inc. CEO to Speak at Executive War College Conference 2XIFIN Inc. CEO to Speak at Executive War College Conference 3US Oncology Launches New Web Site 2US Oncology Launches New Web Site 3US Oncology Launches New Web Site 4US Oncology Launches New Web Site 5US Oncology Launches New Web Site 6Paul Keim Appointed to febit's Scientific Advisory Board 2
(Date:10/25/2014)... 22, 2014 This report covers the specifics ... space in heavy pursuit of research due to its ... compared to other RNA components. miRNA,s non-coding nature and ... candidate for use as a biomarker for a variety ... and diagnostics for the advancement in therapeutic development. Furthermore ...
(Date:10/22/2014)... -- Leading identity analyst firm Acuity Market Intelligence forecasts that ... will have a chip-based National eID card, including near-complete ... Asia , with its vast population, is ... 60% of all National eID cards issued between 2014 ... National eID Industry Report: 2014 Edition" — ...
(Date:10/18/2014)... suspected genetic conditions, a certain type of exome sequencing ... than traditional molecular diagnostic methods, according to a study ... released to coincide with the American Society of Human ... protein­coding region of the genome (the complete set of ... organism), has been rapidly applied in research settings and ...
Breaking Biology News(10 mins):MicroRNA: An Insight to miRNA-based microarrays, diagnostics and therapeutics Overview, Cambridge Healthtech Advisors 2Half the World's Population Will Have Chip-Based National Electronic Identity (eID) Cards by 2018 2Study examines type of exome sequencing and molecular diagnostic yield 2Study examines type of exome sequencing and molecular diagnostic yield 3
... In a paper being presented in two American ... joint Estonian-French team demonstrated "for the first time ... suggesting that mitochondria may mechanically regulate nuclear function." ... over 10 years, reported that it recently "found ...
... of biology's most fundamental questions ?why males produce sperm ... a breakthrough that could lead to improved infertility treatment, ... led by Dr Josephine Bowles and Professor Peter Koopman ... of Queensland, has discovered that derivatives of Vitamin A ...
... Virginia Tech in the United States have determined the ... production xanthurenic acid (XA) in Anopheles gambiae, the malaria ... sexual reproduction of the malaria parasite (Plasmodium falciparum) in ... could be an avenue for development of drugs and ...
Cached Biology News:First direct mechanical communication of mitochondria, cardiomyocyte nucleus shown 2First direct mechanical communication of mitochondria, cardiomyocyte nucleus shown 3One big biology question solved 2Oxidation defense in mosquitoes benefits malaria parasite 2
Reacts with the 80 kDa fragment of the M-chain of human merosin....
ICAD / DFF45 (NT) Affinity Purified Polyclonal Antibody...
... ( Abpromise for all tested ... Synthetic peptide derived from residues 231 ... (Note: the amino acid sequence is ... Entrez Gene ID: 80829 ...
AANAT [Arylalkylamine N-acetyltransferase; EC 2.3.1.87]...
Biology Products: